Leqembi Likes Asia’s Genes. Why?
December 30, 2025
New evidence suggests genetics—not geography—may explain why Leqembi causes fewer ARIA brain side effects in parts of Asia, and what that means for families everywhere.
Search Results for: leqembi – Page 2
Leqembi Prescriptions Could Rise Sharply. Why?
December 21, 2025
Alzheimer’s treatment eligibility may be far larger than previously thought. A major Nature study using blood tests suggests millions more older adults could qualify for treatment than current use reflects. As diagnosis becomes easier, demand for drugs like Leqembi could
Leqembi: Slowing Alzheimer’s — What You Need to Know
November 16, 2025
Leqembi is one of the first Alzheimer’s treatments proven to slow decline. A new MRI study helps explain what it can—and cannot—do in the brain’s early months, offering clearer expectations for caregivers.
New At-Home Leqembi: What It Means for Alzheimer’s
October 7, 2025
IMAGINE THIS: Instead of going to an infusion center for treatment, you can switch to a weekly injection at home. That’s now a reality for many Alzheimer’s patients.
3-Minute ‘Fastball’ Alzheimer’s Test Could Speed Access to Leqembi
September 3, 2025
Access to Leqembi, the new Alzheimer’s drug, has been slowed by lengthy diagnoses. The “Fastball” brainwave test could change that — detecting memory decline earlier and speeding access to treatment.
Leqembi and Kisunla: Inside the Infusion Experience
August 29, 2025
They’re not just pills—they’re precision infusions designed to slow Alzheimer’s at its source. See UCLA’s cutting-edge Amyloid Immunotherapy Care Program, and what it feels like to begin treatment with Leqembi (lecanemab) and Kisunla (donanemab).
“Is Leqembi Worth It?” Costs and the Road to Wider Access
July 22, 2025
Leqembi, the first Alzheimer’s-modifying drug, is a giant step forward—but how many people are getting it, and what does it really cost the average American? We dig into the numbers, the barriers, and the path forward.
How Many Leqembi Patients Are There?
May 5, 2025
Alzheimer’s rates are on the rise. How is today’s best treatment, Leqembi (generic lecanemab) doing in the fight against it?
Leqembi Best at Fighting Alzheimer’s in Men
April 18, 2025
See why Leqembi is even more effective in males than females, at fighting Alzheimer’s.
Leqembi Becomes Europe’s First Alzheimer’s Antibody
April 16, 2025
The European Union authorizes Leqembi as its very first Alzheimer’s drug to target an underlying cause of Alzheimer’s.